LRP10 and Alzheimer disease: Finally, a recent transcriptomic study on extensive AD cohorts demonstrated that LRP10 acts as a key driver of specific molecular subtypes of AD, with its expression being, either upregulated or downregulated in astrocytes, endothelial cells and microglia, depending on the AD subtype analysed [62].